BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17599051)

  • 1. The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity.
    Anastasi S; Baietti MF; Frosi Y; Alemà S; Segatto O
    Oncogene; 2007 Dec; 26(57):7833-46. PubMed ID: 17599051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation.
    Frosi Y; Anastasi S; Ballarò C; Varsano G; Castellani L; Maspero E; Polo S; Alemà S; Segatto O
    J Cell Biol; 2010 May; 189(3):557-71. PubMed ID: 20421427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors.
    Segatto O; Anastasi S; Alemà S
    J Cell Sci; 2011 Jun; 124(Pt 11):1785-93. PubMed ID: 21576352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction of MIG6 under hypoxic conditions is critical for dormancy in primary cultured lung cancer cells with activating EGFR mutations.
    Endo H; Okami J; Okuyama H; Nishizawa Y; Imamura F; Inoue M
    Oncogene; 2017 May; 36(20):2824-2834. PubMed ID: 27893711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine phosphorylation of mig6 reduces its inhibition of the epidermal growth factor receptor.
    Wang Z; Raines LL; Hooy RM; Roberson H; Leahy DJ; Cole PA
    ACS Chem Biol; 2013 Nov; 8(11):2372-6. PubMed ID: 24004111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function.
    Xu D; Makkinje A; Kyriakis JM
    J Biol Chem; 2005 Jan; 280(4):2924-33. PubMed ID: 15556944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of epidermal growth factor receptor is associated with MIG6 expression.
    Nagashima T; Ushikoshi-Nakayama R; Suenaga A; Ide K; Yumoto N; Naruo Y; Takahashi K; Saeki Y; Taiji M; Tanaka H; Tsai SF; Hatakeyama M
    FEBS J; 2009 Sep; 276(18):5239-51. PubMed ID: 19674104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation.
    Ferby I; Reschke M; Kudlacek O; Knyazev P; Pantè G; Amann K; Sommergruber W; Kraut N; Ullrich A; Fässler R; Klein R
    Nat Med; 2006 May; 12(5):568-73. PubMed ID: 16648858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface.
    Zhang X; Pickin KA; Bose R; Jura N; Cole PA; Kuriyan J
    Nature; 2007 Nov; 450(7170):741-4. PubMed ID: 18046415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6.
    Park E; Kim N; Ficarro SB; Zhang Y; Lee BI; Cho A; Kim K; Park AKJ; Park WY; Murray B; Meyerson M; Beroukhim R; Marto JA; Cho J; Eck MJ
    Nat Struct Mol Biol; 2015 Sep; 22(9):703-711. PubMed ID: 26280531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.
    Maity TK; Venugopalan A; Linnoila I; Cultraro CM; Giannakou A; Nemati R; Zhang X; Webster JD; Ritt D; Ghosal S; Hoschuetzky H; Simpson RM; Biswas R; Politi K; Morrison DK; Varmus HE; Guha U
    Cancer Discov; 2015 May; 5(5):534-49. PubMed ID: 25735773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6.
    Menezes SV; Kovacevic Z; Richardson DR
    J Biol Chem; 2019 Mar; 294(11):4045-4064. PubMed ID: 30679310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular insight into the affinity, specificity and cross-reactivity of systematic hepatocellular carcinoma RALT interaction profile with human receptor tyrosine kinases.
    Lu G; Li X; Zhang J; Xu Q
    Amino Acids; 2021 Nov; 53(11):1715-1728. PubMed ID: 34618235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the interactions of EGFR with phosphorylated Mig6 by molecular dynamics simulations and MM-PBSA calculations.
    Zhang Y; Zheng QC
    J Theor Biol; 2018 Jun; 447():118-125. PubMed ID: 29574142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control.
    Fiorini M; Ballarò C; Sala G; Falcone G; Alemà S; Segatto O
    Oncogene; 2002 Sep; 21(42):6530-9. PubMed ID: 12226756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype.
    Ballarò C; Ceccarelli S; Tiveron C; Tatangelo L; Salvatore AM; Segatto O; Alemà S
    EMBO Rep; 2005 Aug; 6(8):755-61. PubMed ID: 16007071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the ErbB network by the MIG6 feedback loop in physiology, tumor suppression and responses to oncogene-targeted therapeutics.
    Anastasi S; Lamberti D; Alemà S; Segatto O
    Semin Cell Dev Biol; 2016 Feb; 50():115-24. PubMed ID: 26456277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin.
    Anastasi S; Sala G; Huiping C; Caprini E; Russo G; Iacovelli S; Lucini F; Ingvarsson S; Segatto O
    Oncogene; 2005 Jun; 24(28):4540-8. PubMed ID: 15856022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of Mig6 negatively regulates the ubiquitination and degradation of EGFR mutants in lung adenocarcinoma cell lines.
    Boopathy GTK; Lynn JLS; Wee S; Gunaratne J; Hong W
    Cell Signal; 2018 Mar; 43():21-31. PubMed ID: 29196224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feedback inhibition by RALT controls signal output by the ErbB network.
    Anastasi S; Fiorentino L; Fiorini M; Fraioli R; Sala G; Castellani L; Alemà S; Alimandi M; Segatto O
    Oncogene; 2003 Jul; 22(27):4221-34. PubMed ID: 12833145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.